These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 21447830)

  • 1. Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor.
    Redell MS; Ruiz MJ; Alonzo TA; Gerbing RB; Tweardy DJ
    Blood; 2011 May; 117(21):5701-9. PubMed ID: 21447830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.
    Redell MS; Ruiz MJ; Gerbing RB; Alonzo TA; Lange BJ; Tweardy DJ; Meshinchi S;
    Blood; 2013 Feb; 121(7):1083-93. PubMed ID: 23243289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.
    Narayanan P; Man TK; Gerbing RB; Ries R; Stevens AM; Wang YC; Long X; Gamis AS; Cooper T; Meshinchi S; Alonzo TA; Redell MS
    Clin Transl Oncol; 2021 Oct; 23(10):2141-2154. PubMed ID: 33948920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells.
    Bi L; Yu Z; Wu J; Yu K; Hong G; Lu Z; Gao S
    Tohoku J Exp Med; 2015 Nov; 237(3):163-72. PubMed ID: 26466521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression.
    Harada M; Benito J; Yamamoto S; Kaur S; Arslan D; Ramirez S; Jacamo R; Platanias L; Matsushita H; Fujimura T; Kazuno S; Kojima K; Tabe Y; Konopleva M
    Oncotarget; 2015 Nov; 6(35):37930-47. PubMed ID: 26473447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib induces apoptosis in HL60 cells by inhibiting Src kinase-mediated STAT3 phosphorylation.
    Zhao W; Zhang T; Qu B; Wu X; Zhu X; Meng F; Gu Y; Shu Y; Shen Y; Sun Y; Xu Q
    Anticancer Drugs; 2011 Jan; 22(1):79-88. PubMed ID: 20881478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of JAK2/STAT3 intensifies the anti-tumor activity of arsenic trioxide in acute myeloid leukemia cells: Novel synergistic mechanism via the mediation of reactive oxygen species.
    Mesbahi Y; Zekri A; Ghaffari SH; Tabatabaie PS; Ahmadian S; Ghavamzadeh A
    Eur J Pharmacol; 2018 Sep; 834():65-76. PubMed ID: 30012499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells.
    Zhao J; Xu Y; Zong Y; Zhang S; Song Y; Yu K; Li Z; Ji Y; Qiu Y; Chen F
    Hematology; 2011 Jul; 16(4):232-5. PubMed ID: 21756540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
    Wierenga AT; Schuringa JJ; Eggen BJ; Kruijer W; Vellenga E
    Leukemia; 2002 Apr; 16(4):675-82. PubMed ID: 11960349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells.
    Chakraborty A; White SM; Schaefer TS; Ball ED; Dyer KF; Tweardy DJ
    Blood; 1996 Oct; 88(7):2442-9. PubMed ID: 8839834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling.
    Wang L; Zhang H; Lei D
    Yonsei Med J; 2019 Oct; 60(10):924-934. PubMed ID: 31538427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells.
    Papa V; Tazzari PL; Chiarini F; Cappellini A; Ricci F; Billi AM; Evangelisti C; Ottaviani E; Martinelli G; Testoni N; McCubrey JA; Martelli AM
    Leukemia; 2008 Jan; 22(1):147-60. PubMed ID: 17928881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
    Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.
    Zhang Q; Hossain DM; Duttagupta P; Moreira D; Zhao X; Won H; Buettner R; Nechaev S; Majka M; Zhang B; Cai Q; Swiderski P; Kuo YH; Forman S; Marcucci G; Kortylewski M
    Blood; 2016 Mar; 127(13):1687-700. PubMed ID: 26796361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO.
    Da Silva N; Meyer-Monard S; Menot ML; Parrado A; Lebel A; Balitrand N; Fenaux P; Micléa JM; Rousselot P; Degos L; Dombret H; Chomienne C
    Hematol J; 2000; 1(5):316-28. PubMed ID: 11920209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cells.
    Samudio IJ; Duvvuri S; Clise-Dwyer K; Watt JC; Mak D; Kantarjian H; Yang D; Ruvolo V; Borthakur G
    Leuk Lymphoma; 2010 May; 51(5):911-919. PubMed ID: 20423286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation.
    Stevens AM; Xiang M; Heppler LN; Tošić I; Jiang K; Munoz JO; Gaikwad AS; Horton TM; Long X; Narayanan P; Seashore EL; Terrell MC; Rashid R; Krueger MJ; Mangubat-Medina AE; Ball ZT; Sumazin P; Walker SR; Hamada Y; Oyadomari S; Redell MS; Frank DA
    Blood Adv; 2019 Dec; 3(24):4215-4227. PubMed ID: 31856268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.
    Chiarini F; Lonetti A; Teti G; Orsini E; Bressanin D; Cappellini A; Ricci F; Tazzari PL; Ognibene A; Falconi M; Pagliaro P; Iacobucci I; Martinelli G; Amadori S; McCubrey JA; Martelli AM
    Oncotarget; 2012 Dec; 3(12):1615-28. PubMed ID: 23271044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.
    Brady MT; Miller A; Sait SN; Ford LA; Minderman H; Wang ES; Lee KP; Baumann H; Wetzler M
    Leuk Res; 2013 Jul; 37(7):822-8. PubMed ID: 23628554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.